Instituto de Neumonología y Dermatología

Buenos Aires C1425BEA

0 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema, Plaque Psoriasis

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis — Completed